Back to Jennison Associates LLC Jennison Associates LLC

TXG

Showing 4 of 12 quarters

Position history for Jennison Associates LLCJennison Associates LLC's holdings in 10x Genomics, Inc.

Yes. Jennison Associates holds 39,861 shares of TXG (10x Genomics), worth $1.5M, as of its Q2 2026 13F filing. It reduced the position by 19,228 shares (-32.5%) from Q1 2026. Jennison Associates has held TXG since Q3 2025, across 4 quarterly 13F filings.

Current Value

$1.5M

Current Shares

39,861

Total Value Change

+$992,786

Total Shares Change

-5,946

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
39,861
-32.5%
$1.5M0.0%$38.34
0
2026-Q1
Decreased
59,089
-11.8%
$1.3M0.0%$22.62
0
2025-Q4
Increased
66,969
+46.2%
$1.1M0.0%$16.29
34
2025-Q3
New
45,807
-
$535,4840.0%$11.34
34

Other major holders of TXG: FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used